Key Market Indicators
Indonesia is on track to achieve 90% vaccination coverage for children aged one year by 2028, up from 89% in 2023. This marks an average annual growth of 0.2 percentage points since 2005, when the coverage rate increased by 0.5 points each year. In a separate milestone, Indonesia aims to reach 88% vaccination coverage for the same age group by 2028, compared to 87% in 2023. This steady yearly growth of 0.2 percentage points has been consistent since 1986, a period during which the market showed no significant variation. On the economic front, Indonesia's vaccine imports are projected to hit approximately $200 million by 2028, rising from around $163 million in 2023. This represents an average annual growth rate of 3.1% since 1994, when demand increased by 4.2% each year. Conversely, vaccine exports from Indonesia are expected to reach nearly $100 million by 2028, up from about $92 million in 2023. With an average yearly growth of 1.1% since 1994, the supply has risen by 3.5% annually. As of 2023, Indonesia ranks 19th globally in vaccine exports, with Hungary surpassing it at the same export value. Belgium, the United Kingdom, and France hold the second, third, and fourth positions, respectively. Lastly, Indonesia's vaccination coverage for children aged one year is anticipated to maintain a steady rate of 80% through 2028, unchanged from 2023. This stability has been observed since 1986, indicating a consistent market trend.
